DHR Stock: Danaher Corporation Stock Price, Analysis & Insights
Get live DHR stock price $188.07, comprehensive Danaher Corporation stock analysis, charts, news, and expert forecast. Real-time DHR stock data and investment insights.
Loading chart data...
Danaher Corporation (DHR) Overview
Danaher Corporation (DHR) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, DHR trades at $188.07 with a market capitalization of 133.11B . Over the past 52 weeks, DHR has traded between $160.93 and $242.80 , with the current price positioned at approximately 33% of this range . The stock...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 133.11B
- Current price: $188.07
- 52-week range: $160.93 - $242.80
- P/E ratio: 36.45
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The o...
Company Information
- CEO
- Rainer Blair
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 61000
Contact Information
- Website
- https://www.danaher.com
- Address
- 2200 Pennsylvania Avenue, NW
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 133.1 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 36.5)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Danaher Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Danaher Corporation
- ⚠Investors should consider how Danaher Corporation fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 36.5) requires strong growth to justify
Market Cap
133.11B
P/E Ratio (TTM)
36.45
Beta
0.83
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare DHR with peer companies:
- Price
- $347.74
- Market cap
- 187.68B
- Price
- $48.51
- Market cap
- 72.10B
- Price
- $123.46
- Market cap
- 153.28B
- Price
- $421.45
- Market cap
- 149.26B
- Price
- $790.31
- Market cap
- 95.00B
- Price
- $81.42
- Market cap
- 104.53B
- Price
- $25.69
- Market cap
- 146.42B
- Price
- $43.97
- Market cap
- 105.72B
- Price
- $314.14
- Market cap
- 120.43B
- Price
- $493.66
- Market cap
- 183.45B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.